CapMedic is a state-of-the-art Class II FDA-cleared solution to remotely monitor and manage Asthma and COPD patients. 

• At the core, it includes a fun, interactive smart inhaler that verbally coaches patients in real-time for regular and correct use. 
• The same device doubles as a smart inhaler to regularly monitor lung function. 
• Without needing to connect to an app, it only takes a few seconds for patients to understand their control and use inhalers correctly but also for clinicians to seamlessly receive rich medication and lung function information. 
• For very young, at-risk, and elderly patients for whom early detection is paramount, the solution includes the first FDA-cleared home usable oscillometry test that requires no forced breathing.

CapMedic is shown to significantly improve inhaler use in published pilots. In a recent pilot, the solution showed 1 week early COPD exacerbation detection capabilities using effort-free oscillometry testing.

Cognita Labs is a California-based respiratory devices innovator with industry first two class II FDA clearances. The company has received prestigious research awards from both NIH and NIH totaling $4M. This means our work has gone through a rigorous review process by both researchers and FDA.

The platform can provide seamless login via SAML-based organization directory sync

• Unparalleled visualizations of inhaler use, lung function, and symptom score tracking.
• Rich reporting
• Customizable alerts
• Automated and manual patient communication via text messaging 

• The first and only live interactive smart inhaler that coaches for inhaler use
• The first and only smart inhaler with sensitive flow sensing that combines smart inhaler and smart spirometer function in one resulting in a single multi-function fun device that patients love
• First reusable and rechargeable device. First, that connects to major MDIs without a change of electronics making it the most environment-friendly product.
• First smart spirometer that requires no app connection for feedback. Results in high patient satisfaction due to the significantly short time commitment per day resulting in high compliance.
• Most comprehensive medication monitoring that includes all MDIs, DPI, and soft mist inhalers.
• Combines most sensitive biomarkers such as spirometry, the technique of inhaler use, and the first FDA-cleared home-use oscillometry test (sensitive lung function assessment without forced breathing)